PALI

Palisade Bio, INC.

Insider trading activity for Palisade Bio, INC., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

+$28.8K

net buying

Bought(2 · 1 insiders): $28.8K
Sold(0 · 0 insiders): $0

Past 6 months

-$130.9K

net selling

Bought(8 · 2 insiders): $279K
Sold(2 · 2 insiders): $409.9K

Past 12 months

-$123.4K

net selling

Bought(10 · 2 insiders): $296.7K
Sold(4 · 2 insiders): $420.2K

Transaction history

The 59 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Oct 19	Capers Julien E.	See Remarks	AGRANT	787,300	—	—	—	Open the original filing on SEC.gov
Oct 6	Finley John David	CEO CFO	MEXER◆	167,584	—	—	—	Open the original filing on SEC.gov
Oct 6	Finley John David	CEO CFO	MEXER◆	3.1M	—	—	—	Open the original filing on SEC.gov
Oct 6	Finley John David	CEO CFO	FTAX	1.4M	$1.49	$2.1M	-42.1%	Open the original filing on SEC.gov
Oct 6	Finley John David	CEO CFO	MEXER	3.2M	—	—	+2,496%	Open the original filing on SEC.gov
Oct 6	Jones Mitchell Lawrence	See Remarks	MEXER◆	65,584	—	—	—	Open the original filing on SEC.gov
Oct 6	Jones Mitchell Lawrence	See Remarks	MEXER◆	2.6M	—	—	—	Open the original filing on SEC.gov
Oct 6	Jones Mitchell Lawrence	See Remarks	FTAX	1M	$1.49	$1.5M	-38.0%	Open the original filing on SEC.gov
Oct 6	Jones Mitchell Lawrence	See Remarks	MEXER	2.6M	—	—	+2,788%	Open the original filing on SEC.gov
Oct 2	Williams Donald Allen	Director	PBUY	10,000	$1.46	$14.6K	+0.6%	Open the original filing on SEC.gov
Oct 1	Williams Donald Allen	Director	PBUY↓	10,000	$1.42	$14.2K	+0.6%	Open the original filing on SEC.gov
Aug 19	Finley John David	CEO, CFO	GGIFT	88,400	—	—	+173,333%	Open the original filing on SEC.gov
Aug 19	Finley John David	CEO, CFO	GGIFT	88,400	—	—	-40.6%	Open the original filing on SEC.gov
Jul 9	Baltera Robert Jr.	Director	PBUY	25,000	$1.96	$48.9K	+5.7%	Open the original filing on SEC.gov
Jul 8	Baltera Robert Jr.	Director	PBUY	20,000	$1.99	$39.8K	+4.8%	Open the original filing on SEC.gov
Jul 7	Jones Mitchell Lawrence	Chief Medical Officer	SSELL	51,880	$2.05	$106.5K	-35.6%	Open the original filing on SEC.gov
Jul 7	Finley John David	CEO, CFO	MEXER◆	133	—	—	—	Open the original filing on SEC.gov
Jul 7	Finley John David	CEO, CFO	MEXER	133	$0.7	$93	+<0.1%	Open the original filing on SEC.gov
Jul 7	Finley John David	CEO, CFO	SSELL	146,798	$2.07	$303.3K	-40.3%	Open the original filing on SEC.gov
Jul 7	Baltera Robert Jr.	Director	PBUY	30,000	$2.03	$61K	+7.8%	Open the original filing on SEC.gov
Jul 6	Jones Mitchell Lawrence	Chief Medical Officer	MEXER◆	131,167	—	—	—	Open the original filing on SEC.gov
Jul 6	Jones Mitchell Lawrence	Chief Medical Officer	MEXER	131,167	—	—	+891.0%	Open the original filing on SEC.gov
Jul 6	Finley John David	CEO, CFO	MEXER◆	335,167	—	—	—	Open the original filing on SEC.gov
Jul 6	Finley John David	CEO, CFO	MEXER	335,167	—	—	+1,148%	Open the original filing on SEC.gov
Jul 6	Baltera Robert Jr.	Director	PBUY	20,000	$2.05	$41K	+5.5%	Open the original filing on SEC.gov
Jul 2	Baltera Robert Jr.	Director	PBUY	10,000	$1.98	$19.8K	+2.8%	Open the original filing on SEC.gov
Jul 1	Baltera Robert Jr.	Director	PBUY★	20,000	$1.98	$39.6K	+5.9%	Open the original filing on SEC.gov
Jun 10	Wei Binxian	Director	MEXER◆	20,200	—	—	—	Open the original filing on SEC.gov
Jun 10	Wei Binxian	Director	MEXER	20,200	—	—	+3.4%	Open the original filing on SEC.gov
Jun 10	Wei Binxian	Director	AGRANT	592,300	—	—	+69,275%	Open the original filing on SEC.gov
Jun 10	Williams Donald Allen	Director	MEXER◆	60,666	—	—	—	Open the original filing on SEC.gov
Jun 10	Williams Donald Allen	Director	MEXER	60,666	—	—	+4.0%	Open the original filing on SEC.gov
Jun 10	Williams Donald Allen	Director	AGRANT	1.5M	—	—	+13,972%	Open the original filing on SEC.gov
Jun 10	Zwick Jordan Michael	Director	AGRANT	336,904	—	—	—	Open the original filing on SEC.gov
Jun 10	Chuang Emil	Director	MEXER◆	20,200	—	—	—	Open the original filing on SEC.gov
Jun 10	Chuang Emil	Director	MEXER	20,200	—	—	+3.4%	Open the original filing on SEC.gov
Jun 10	Chuang Emil	Director	AGRANT	592,300	—	—	—	Open the original filing on SEC.gov
Jun 10	Baltera Robert Jr.	Director	AGRANT	336,904	—	—	—	Open the original filing on SEC.gov
Feb 12	Jones Mitchell Lawrence	Chief Medical Officer	SSELL	1,989	$1.75	$3.5K	-13.0%	Open the original filing on SEC.gov
Feb 12	Finley John David	CEO, CFO	SSELL	3,896	$1.75	$6.8K	-12.5%	Open the original filing on SEC.gov
Feb 11	Jones Mitchell Lawrence	Chief Medical Officer	MEXER◆	8,000	—	—	—	Open the original filing on SEC.gov
Feb 11	Jones Mitchell Lawrence	Chief Medical Officer	MEXER	8,000	—	—	+110.3%	Open the original filing on SEC.gov
Feb 11	Finley John David	CEO, CFO	MEXER◆	13,333	—	—	—	Open the original filing on SEC.gov
Feb 11	Finley John David	CEO, CFO	MEXER	13,333	—	—	+74.4%	Open the original filing on SEC.gov
Feb 9	Jones Mitchell Lawrence	Chief Medical Officer	AGRANT◆	787,000	—	—	—	Open the original filing on SEC.gov
Feb 9	Finley John David	CEO, CFO	AGRANT◆	2M	—	—	—	Open the original filing on SEC.gov
Jan 16	Williams Donald Allen	Director	PBUY	5,000	$1.67	$8.4K	+87.3%	Open the original filing on SEC.gov
Jan 9	Williams Donald Allen	Director	PBUY	5,000	$1.88	$9.4K	+686.8%	Open the original filing on SEC.gov
Oct 6, 2025	Jones Mitchell Lawrence	Chief Medical Officer	AGRANT◆	7.7M	—	—	—	Open the original filing on SEC.gov
Oct 6, 2025	Finley John David	CEO, CFO	AGRANT◆	9.2M	—	—	—	Open the original filing on SEC.gov
Oct 6, 2025	Williams Donald Allen	Director	AGRANT◆↺	182,000	—	—	—	Open the original filing on SEC.gov
Oct 6, 2025	Wei Binxian	Director	AGRANT◆↺	60,600	—	—	—	Open the original filing on SEC.gov
Oct 6, 2025	Chuang Emil	Director	AGRANT◆↺	60,600	—	—	—	Open the original filing on SEC.gov
Sep 4, 2025	Williams Donald Allen	Director	AGRANT◆	64,400	—	—	—	Open the original filing on SEC.gov
Sep 4, 2025	Wei Binxian	Director	AGRANT◆	18,800	—	—	—	Open the original filing on SEC.gov
Sep 4, 2025	Jones Mitchell Lawrence	Chief Medical Officer	AGRANT◆	289,000	—	—	—	Open the original filing on SEC.gov
Sep 4, 2025	Finley John David	CEO, CFO	AGRANT◆	323,400	—	—	—	Open the original filing on SEC.gov
Sep 4, 2025	Chuang Emil	Director	AGRANT◆	18,800	—	—	—	Open the original filing on SEC.gov
Jul 18, 2025	Chuang Emil	Director	AGRANT◆	8,000	—	—	—	Open the original filing on SEC.gov

AGRANT—

Capers Julien E. · See RemarksOct 19

787,300 sh

MEXER◆—

Finley John David · CEO CFOOct 6

167,584 sh

MEXER◆—

Finley John David · CEO CFOOct 6

3.1M sh

FTAX$2.1M

Finley John David · CEO CFOOct 6

1.4M sh @ $1.49 · -42.1% own

MEXER—

Finley John David · CEO CFOOct 6

3.2M sh · +2,496% own

MEXER◆—

Jones Mitchell Lawrence · See RemarksOct 6

65,584 sh

MEXER◆—

Jones Mitchell Lawrence · See RemarksOct 6

2.6M sh

FTAX$1.5M

Jones Mitchell Lawrence · See RemarksOct 6

1M sh @ $1.49 · -38.0% own

MEXER—

Jones Mitchell Lawrence · See RemarksOct 6

2.6M sh · +2,788% own

PBUY$14.6K

Williams Donald Allen · DirectorOct 2

10,000 sh @ $1.46 · +0.6% own

PBUY↓$14.2K

Williams Donald Allen · DirectorOct 1

10,000 sh @ $1.42 · +0.6% own

GGIFT—

Finley John David · CEO, CFOAug 19

88,400 sh · +173,333% own

GGIFT—

Finley John David · CEO, CFOAug 19

88,400 sh · -40.6% own

PBUY$48.9K

Baltera Robert Jr. · DirectorJul 9

25,000 sh @ $1.96 · +5.7% own

PBUY$39.8K

Baltera Robert Jr. · DirectorJul 8

20,000 sh @ $1.99 · +4.8% own

SSELL$106.5K

Jones Mitchell Lawrence · Chief Medical…Jul 7

51,880 sh @ $2.05 · -35.6% own

MEXER◆—

Finley John David · CEO, CFOJul 7

133 sh

MEXER$93

Finley John David · CEO, CFOJul 7

133 sh @ $0.7 · +<0.1% own

SSELL$303.3K

Finley John David · CEO, CFOJul 7

146,798 sh @ $2.07 · -40.3% own

PBUY$61K

Baltera Robert Jr. · DirectorJul 7

30,000 sh @ $2.03 · +7.8% own

MEXER◆—

Jones Mitchell Lawrence · Chief Medical…Jul 6

131,167 sh

MEXER—

Jones Mitchell Lawrence · Chief Medical…Jul 6

131,167 sh · +891.0% own

MEXER◆—

Finley John David · CEO, CFOJul 6

335,167 sh

MEXER—

Finley John David · CEO, CFOJul 6

335,167 sh · +1,148% own

PBUY$41K

Baltera Robert Jr. · DirectorJul 6

20,000 sh @ $2.05 · +5.5% own

PBUY$19.8K

Baltera Robert Jr. · DirectorJul 2

10,000 sh @ $1.98 · +2.8% own

PBUY★$39.6K

Baltera Robert Jr. · DirectorJul 1

20,000 sh @ $1.98 · +5.9% own

MEXER◆—

Wei Binxian · DirectorJun 10

20,200 sh

MEXER—

Wei Binxian · DirectorJun 10

20,200 sh · +3.4% own

AGRANT—

Wei Binxian · DirectorJun 10

592,300 sh · +69,275% own

MEXER◆—

Williams Donald Allen · DirectorJun 10

60,666 sh

MEXER—

Williams Donald Allen · DirectorJun 10

60,666 sh · +4.0% own

AGRANT—

Williams Donald Allen · DirectorJun 10

1.5M sh · +13,972% own

AGRANT—

Zwick Jordan Michael · DirectorJun 10

336,904 sh

MEXER◆—

Chuang Emil · DirectorJun 10

20,200 sh

MEXER—

Chuang Emil · DirectorJun 10

20,200 sh · +3.4% own

AGRANT—

Chuang Emil · DirectorJun 10

592,300 sh

AGRANT—

Baltera Robert Jr. · DirectorJun 10

336,904 sh

SSELL$3.5K

Jones Mitchell Lawrence · Chief Medical…Feb 12

1,989 sh @ $1.75 · -13.0% own

SSELL$6.8K

Finley John David · CEO, CFOFeb 12

3,896 sh @ $1.75 · -12.5% own

MEXER◆—

Jones Mitchell Lawrence · Chief Medical…Feb 11

8,000 sh

MEXER—

Jones Mitchell Lawrence · Chief Medical…Feb 11

8,000 sh · +110.3% own

MEXER◆—

Finley John David · CEO, CFOFeb 11

13,333 sh

MEXER—

Finley John David · CEO, CFOFeb 11

13,333 sh · +74.4% own

AGRANT◆—

Jones Mitchell Lawrence · Chief Medical…Feb 9

787,000 sh

AGRANT◆—

Finley John David · CEO, CFOFeb 9

2M sh

PBUY$8.4K

Williams Donald Allen · DirectorJan 16

5,000 sh @ $1.67 · +87.3% own

PBUY$9.4K

Williams Donald Allen · DirectorJan 9

5,000 sh @ $1.88 · +686.8% own

AGRANT◆—

Jones Mitchell Lawrence · Chief Medical…Oct 6, 2025

7.7M sh

AGRANT◆—

Finley John David · CEO, CFOOct 6, 2025

9.2M sh

AGRANT◆↺—

Williams Donald Allen · DirectorOct 6, 2025

182,000 sh

AGRANT◆↺—

Wei Binxian · DirectorOct 6, 2025

60,600 sh

AGRANT◆↺—

Chuang Emil · DirectorOct 6, 2025

60,600 sh

AGRANT◆—

Williams Donald Allen · DirectorSep 4, 2025

64,400 sh

AGRANT◆—

Wei Binxian · DirectorSep 4, 2025

18,800 sh

AGRANT◆—

Jones Mitchell Lawrence · Chief Medical…Sep 4, 2025

289,000 sh

AGRANT◆—

Finley John David · CEO, CFOSep 4, 2025

323,400 sh

AGRANT◆—

Chuang Emil · DirectorSep 4, 2025

18,800 sh

AGRANT◆—

Chuang Emil · DirectorJul 18, 2025

8,000 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

1 of 29 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 3 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Jun 10	Jun 17	Baltera Robert Jr.Director	3days	—	Filing ↗

Baltera Robert Jr.Director

3days

Traded Jun 10 · filed Jun 17Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →